40495-V08H1 Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    Cell Signaling Technology Inc anti ctcf
    TERT promoter methylation. Methylation pattern relative to the transcription start site (TSS) in either cell lines (CL) or patient blood/tumor samples (PS) with positive telomerase expression given in black and white rectangles, with black denoting hypermethylated regions and white denoting hypomethylated regions. Cancer abbreviations are: breast (BRCA), lung (LUN), colon (COL), cervical (CES), acute myeloid leukemia (AML), hepatocellular carcinoma (HCC), acute promyelocytic leukemia (APL), bladder (BLA), and glioblastoma (GBM). Transcription factor binding sites for <t>MYC,</t> ETS, and <t>CTCF</t> are shown, with the minimal promoter represented by a dashed arrow, and TERT promoter mutations indicated by *. The proximal MYC site is shaded to denote a lesser importance in transcriptional activation.1 The translation start site is depicted by a dashed arrow head. The amplicons designed to tile the promoter are shown by the dark double arrowhead.
    Anti Ctcf, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti ctcf/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti ctcf - by Bioz Stars, 2021-06
    94/100 stars
      Buy from Supplier

    92
    Thermo Fisher anti gabpa
    Transcription factor binding varies at the TERT promoter in DTC cell lines and normal thyroid tissue. Binding was measured relative to 5% input chromatin, and binding at the TERT locus normalized to a positive control locus for each factor in the indicated cell lines and normal thyroid tissue by ChIP-qPCR for (A) <t>CTCF,</t> (B) <t>GABPA,</t> (C) MYC, at two positions- the minimal promoter binding site and the upstream binding site, (D) GSC. All error bars represent standard error within triplicates.
    Anti Gabpa, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti gabpa/product/Thermo Fisher
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti gabpa - by Bioz Stars, 2021-06
    92/100 stars
      Buy from Supplier

    92
    Thermo Fisher anti gsc
    Transcription factor binding varies at the TERT promoter in DTC cell lines and normal thyroid tissue. Binding was measured relative to 5% input chromatin, and binding at the TERT locus normalized to a positive control locus for each factor in the indicated cell lines and normal thyroid tissue by ChIP-qPCR for (A) CTCF, (B) GABPA, (C) <t>MYC,</t> at two positions- the minimal promoter binding site and the upstream binding site, (D) <t>GSC.</t> All error bars represent standard error within triplicates.
    Anti Gsc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti gsc/product/Thermo Fisher
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti gsc - by Bioz Stars, 2021-06
    92/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc anti myc
    TERT promoter methylation. Methylation pattern relative to the transcription start site (TSS) in either cell lines (CL) or patient blood/tumor samples (PS) with positive telomerase expression given in black and white rectangles, with black denoting hypermethylated regions and white denoting hypomethylated regions. Cancer abbreviations are: breast (BRCA), lung (LUN), colon (COL), cervical (CES), acute myeloid leukemia (AML), hepatocellular carcinoma (HCC), acute promyelocytic leukemia (APL), bladder (BLA), and glioblastoma (GBM). Transcription factor binding sites for <t>MYC,</t> ETS, and <t>CTCF</t> are shown, with the minimal promoter represented by a dashed arrow, and TERT promoter mutations indicated by *. The proximal MYC site is shaded to denote a lesser importance in transcriptional activation.1 The translation start site is depicted by a dashed arrow head. The amplicons designed to tile the promoter are shown by the dark double arrowhead.
    Anti Myc, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti myc/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti myc - by Bioz Stars, 2021-06
    99/100 stars
      Buy from Supplier

    Image Search Results


    TERT promoter methylation. Methylation pattern relative to the transcription start site (TSS) in either cell lines (CL) or patient blood/tumor samples (PS) with positive telomerase expression given in black and white rectangles, with black denoting hypermethylated regions and white denoting hypomethylated regions. Cancer abbreviations are: breast (BRCA), lung (LUN), colon (COL), cervical (CES), acute myeloid leukemia (AML), hepatocellular carcinoma (HCC), acute promyelocytic leukemia (APL), bladder (BLA), and glioblastoma (GBM). Transcription factor binding sites for MYC, ETS, and CTCF are shown, with the minimal promoter represented by a dashed arrow, and TERT promoter mutations indicated by *. The proximal MYC site is shaded to denote a lesser importance in transcriptional activation.1 The translation start site is depicted by a dashed arrow head. The amplicons designed to tile the promoter are shown by the dark double arrowhead.

    Journal: Genes, chromosomes & cancer

    Article Title: Characterization of Human Telomerase Reverse Transcriptase Promoter Methylation and Transcription Factor Binding in Differentiated Thyroid Cancer Cell Lines

    doi: 10.1002/gcc.22735

    Figure Lengend Snippet: TERT promoter methylation. Methylation pattern relative to the transcription start site (TSS) in either cell lines (CL) or patient blood/tumor samples (PS) with positive telomerase expression given in black and white rectangles, with black denoting hypermethylated regions and white denoting hypomethylated regions. Cancer abbreviations are: breast (BRCA), lung (LUN), colon (COL), cervical (CES), acute myeloid leukemia (AML), hepatocellular carcinoma (HCC), acute promyelocytic leukemia (APL), bladder (BLA), and glioblastoma (GBM). Transcription factor binding sites for MYC, ETS, and CTCF are shown, with the minimal promoter represented by a dashed arrow, and TERT promoter mutations indicated by *. The proximal MYC site is shaded to denote a lesser importance in transcriptional activation.1 The translation start site is depicted by a dashed arrow head. The amplicons designed to tile the promoter are shown by the dark double arrowhead.

    Article Snippet: The following antibodies were used (10 µg per ChIP): anti-CTCF (#2899, Cell Signaling Technology, Danvers, CA), anti-MYC (#9402, Cell Signaling Technology), anti-GABPA (#27795, ThermoFisher), and anti-GSC (#40495, ThermoFisher).

    Techniques: Methylation, Expressing, Binding Assay, Activation Assay

    Transcription factor binding varies at the TERT promoter in DTC cell lines and normal thyroid tissue. Binding was measured relative to 5% input chromatin, and binding at the TERT locus normalized to a positive control locus for each factor in the indicated cell lines and normal thyroid tissue by ChIP-qPCR for (A) CTCF, (B) GABPA, (C) MYC, at two positions- the minimal promoter binding site and the upstream binding site, (D) GSC. All error bars represent standard error within triplicates.

    Journal: Genes, chromosomes & cancer

    Article Title: Characterization of Human Telomerase Reverse Transcriptase Promoter Methylation and Transcription Factor Binding in Differentiated Thyroid Cancer Cell Lines

    doi: 10.1002/gcc.22735

    Figure Lengend Snippet: Transcription factor binding varies at the TERT promoter in DTC cell lines and normal thyroid tissue. Binding was measured relative to 5% input chromatin, and binding at the TERT locus normalized to a positive control locus for each factor in the indicated cell lines and normal thyroid tissue by ChIP-qPCR for (A) CTCF, (B) GABPA, (C) MYC, at two positions- the minimal promoter binding site and the upstream binding site, (D) GSC. All error bars represent standard error within triplicates.

    Article Snippet: The following antibodies were used (10 µg per ChIP): anti-CTCF (#2899, Cell Signaling Technology, Danvers, CA), anti-MYC (#9402, Cell Signaling Technology), anti-GABPA (#27795, ThermoFisher), and anti-GSC (#40495, ThermoFisher).

    Techniques: Binding Assay, Positive Control, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction

    Transcription factor binding varies at the TERT promoter in DTC cell lines and normal thyroid tissue. Binding was measured relative to 5% input chromatin, and binding at the TERT locus normalized to a positive control locus for each factor in the indicated cell lines and normal thyroid tissue by ChIP-qPCR for (A) CTCF, (B) GABPA, (C) MYC, at two positions- the minimal promoter binding site and the upstream binding site, (D) GSC. All error bars represent standard error within triplicates.

    Journal: Genes, chromosomes & cancer

    Article Title: Characterization of Human Telomerase Reverse Transcriptase Promoter Methylation and Transcription Factor Binding in Differentiated Thyroid Cancer Cell Lines

    doi: 10.1002/gcc.22735

    Figure Lengend Snippet: Transcription factor binding varies at the TERT promoter in DTC cell lines and normal thyroid tissue. Binding was measured relative to 5% input chromatin, and binding at the TERT locus normalized to a positive control locus for each factor in the indicated cell lines and normal thyroid tissue by ChIP-qPCR for (A) CTCF, (B) GABPA, (C) MYC, at two positions- the minimal promoter binding site and the upstream binding site, (D) GSC. All error bars represent standard error within triplicates.

    Article Snippet: The following antibodies were used (10 µg per ChIP): anti-CTCF (#2899, Cell Signaling Technology, Danvers, CA), anti-MYC (#9402, Cell Signaling Technology), anti-GABPA (#27795, ThermoFisher), and anti-GSC (#40495, ThermoFisher).

    Techniques: Binding Assay, Positive Control, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction

    Transcription factor binding varies at the TERT promoter in DTC cell lines and normal thyroid tissue. Binding was measured relative to 5% input chromatin, and binding at the TERT locus normalized to a positive control locus for each factor in the indicated cell lines and normal thyroid tissue by ChIP-qPCR for (A) CTCF, (B) GABPA, (C) MYC, at two positions- the minimal promoter binding site and the upstream binding site, (D) GSC. All error bars represent standard error within triplicates.

    Journal: Genes, chromosomes & cancer

    Article Title: Characterization of Human Telomerase Reverse Transcriptase Promoter Methylation and Transcription Factor Binding in Differentiated Thyroid Cancer Cell Lines

    doi: 10.1002/gcc.22735

    Figure Lengend Snippet: Transcription factor binding varies at the TERT promoter in DTC cell lines and normal thyroid tissue. Binding was measured relative to 5% input chromatin, and binding at the TERT locus normalized to a positive control locus for each factor in the indicated cell lines and normal thyroid tissue by ChIP-qPCR for (A) CTCF, (B) GABPA, (C) MYC, at two positions- the minimal promoter binding site and the upstream binding site, (D) GSC. All error bars represent standard error within triplicates.

    Article Snippet: The following antibodies were used (10 µg per ChIP): anti-CTCF (#2899, Cell Signaling Technology, Danvers, CA), anti-MYC (#9402, Cell Signaling Technology), anti-GABPA (#27795, ThermoFisher), and anti-GSC (#40495, ThermoFisher).

    Techniques: Binding Assay, Positive Control, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction

    TERT promoter methylation. Methylation pattern relative to the transcription start site (TSS) in either cell lines (CL) or patient blood/tumor samples (PS) with positive telomerase expression given in black and white rectangles, with black denoting hypermethylated regions and white denoting hypomethylated regions. Cancer abbreviations are: breast (BRCA), lung (LUN), colon (COL), cervical (CES), acute myeloid leukemia (AML), hepatocellular carcinoma (HCC), acute promyelocytic leukemia (APL), bladder (BLA), and glioblastoma (GBM). Transcription factor binding sites for MYC, ETS, and CTCF are shown, with the minimal promoter represented by a dashed arrow, and TERT promoter mutations indicated by *. The proximal MYC site is shaded to denote a lesser importance in transcriptional activation.1 The translation start site is depicted by a dashed arrow head. The amplicons designed to tile the promoter are shown by the dark double arrowhead.

    Journal: Genes, chromosomes & cancer

    Article Title: Characterization of Human Telomerase Reverse Transcriptase Promoter Methylation and Transcription Factor Binding in Differentiated Thyroid Cancer Cell Lines

    doi: 10.1002/gcc.22735

    Figure Lengend Snippet: TERT promoter methylation. Methylation pattern relative to the transcription start site (TSS) in either cell lines (CL) or patient blood/tumor samples (PS) with positive telomerase expression given in black and white rectangles, with black denoting hypermethylated regions and white denoting hypomethylated regions. Cancer abbreviations are: breast (BRCA), lung (LUN), colon (COL), cervical (CES), acute myeloid leukemia (AML), hepatocellular carcinoma (HCC), acute promyelocytic leukemia (APL), bladder (BLA), and glioblastoma (GBM). Transcription factor binding sites for MYC, ETS, and CTCF are shown, with the minimal promoter represented by a dashed arrow, and TERT promoter mutations indicated by *. The proximal MYC site is shaded to denote a lesser importance in transcriptional activation.1 The translation start site is depicted by a dashed arrow head. The amplicons designed to tile the promoter are shown by the dark double arrowhead.

    Article Snippet: The following antibodies were used (10 µg per ChIP): anti-CTCF (#2899, Cell Signaling Technology, Danvers, CA), anti-MYC (#9402, Cell Signaling Technology), anti-GABPA (#27795, ThermoFisher), and anti-GSC (#40495, ThermoFisher).

    Techniques: Methylation, Expressing, Binding Assay, Activation Assay

    Transcription factor binding varies at the TERT promoter in DTC cell lines and normal thyroid tissue. Binding was measured relative to 5% input chromatin, and binding at the TERT locus normalized to a positive control locus for each factor in the indicated cell lines and normal thyroid tissue by ChIP-qPCR for (A) CTCF, (B) GABPA, (C) MYC, at two positions- the minimal promoter binding site and the upstream binding site, (D) GSC. All error bars represent standard error within triplicates.

    Journal: Genes, chromosomes & cancer

    Article Title: Characterization of Human Telomerase Reverse Transcriptase Promoter Methylation and Transcription Factor Binding in Differentiated Thyroid Cancer Cell Lines

    doi: 10.1002/gcc.22735

    Figure Lengend Snippet: Transcription factor binding varies at the TERT promoter in DTC cell lines and normal thyroid tissue. Binding was measured relative to 5% input chromatin, and binding at the TERT locus normalized to a positive control locus for each factor in the indicated cell lines and normal thyroid tissue by ChIP-qPCR for (A) CTCF, (B) GABPA, (C) MYC, at two positions- the minimal promoter binding site and the upstream binding site, (D) GSC. All error bars represent standard error within triplicates.

    Article Snippet: The following antibodies were used (10 µg per ChIP): anti-CTCF (#2899, Cell Signaling Technology, Danvers, CA), anti-MYC (#9402, Cell Signaling Technology), anti-GABPA (#27795, ThermoFisher), and anti-GSC (#40495, ThermoFisher).

    Techniques: Binding Assay, Positive Control, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction